This website uses cookies
Read our Privacy policy and Terms of use for more information.
Find the content you are looking for on Diabetech by searching the desired device, company, or topic.
Aug 11, 2025
•
1 min read
Medications like Ozempic, Wegovy, and Mounjaro are showing promising results for people with type 1 diabetes — but they’re still not approved for this use.
Medtronic's new CGM built by Abbott is 510(k) pending and under FDA review, signaling major changes ahead for MiniMed insulin pumps.
Aug 4, 2025
AI apps can already track your meals with photos and voice—soon, it’ll help manage your diabetes like a personal coach.
Jul 29, 2025
2 min read
The tubeless add-on for Tandem's Mobi insulin pump will give users an untethered wear option and challenge competitors to innovate faster.
Jul 28, 2025
Before any company had a commercial AID system, a misdiagnosed techie and a band of DIYers rewrote the future of diabetes by combining pump and cgm data.
Jul 22, 2025
Tandem’s SteadiSet received FDA 510(k) clearance for 7-day wear and is expected to release in 2026 for multiple pumps.